SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001140361-22-020322
Filing Date
2022-05-24
Accepted
2022-05-23 20:53:28
Documents
7

Document Format Files

Seq Description Document Type Size
1 SC TO-C ny20004305x4_sctoc.htm SC TO-C 44844
2 EXHIBIT 2.1 ny20004305x4_ex2-1.htm EX-2.1 461636
3 EXHIBIT 10.1 ny20004305x4_ex10-1.htm EX-10.1 40798
4 EXHIBIT 99.1 ny20004305x4_ex99-1.htm EX-99.1 85083
5 EXHIBIT 99.2 ny20004305x4_ex99-2.htm EX-99.2 86015
6 EXHIBIT 99.3 ny20004305x4_ex99-3.htm EX-99.3 26808
7 image2.jpg GRAPHIC 1091
  Complete submission text file 0001140361-22-020322.txt   748643
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filed by) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Subject) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-90651 | Film No.: 22953629
SIC: 2834 Pharmaceutical Preparations